Diagnostic News and Research

RSS

Enzo Biochem generating more than $100M in revenues annually

Enzo Biochem, Inc. is well positioned to benefit from the results of its transformation involving acquisitions, new managements at each of its major subsidiaries and a heightened focus on new life science, diagnostic and therapeutic products, Barry Weiner, President, told the annual meeting of shareholders today.

30 Jan 2010

USPTO allows claims to Rosetta Genomics' two microRNA related patent applications

Rosetta Genomics today announced that the United States Patent and Trademark Office has allowed claims in two patent applications.

30 Jan 2010

PeaceHealth-San Juan Island community's new hospital initiative receives Certificate of Need approval

State of Washington Department of Health (DOH) officials approved a Certificate of Need for a new critical access hospital on San Juan Island. The new facility will be owned and operated by PeaceHealth, a regional health system that serves communities in Washington, Oregon and Alaska.

30 Jan 2010

Redwood Consultants to assist DMI Life Sciences in shareholder relations and investor communications

DMI Life Sciences, Inc., which recently announced that it has entered into a non-binding letter of intent with Imagine Media, Ltd. is pleased to announce today that the Company has retained California-based Redwood Consultants, LLC to assist in shareholder relations and investor communications.

30 Jan 2010

Cardiologist provides heart-healthy tips for women

Heart disease is the single leading cause of death for American women. Nearly twice as many women in the United States die of heart disease, stroke and other cardiovascular diseases than from all forms of cancer, including breast cancer.

30 Jan 2010

Rubicon Genomics reaches agreement with ZyGEM to market its PicoPlex single-cell amplification kits

Rubicon Genomics, Inc., a developer of pre-analytical amplification products that enable more comprehensive genetic analysis of clinical and research samples, announced today that it has reached agreement with ZyGEM to non-exclusively market Rubicon's PicoPlex™ single-cell amplification kits in Australia and New Zealand.

30 Jan 2010

Recent releases in Global Health

Rajiv Shah's appointment as USAID administrator "comes at a crucial time of challenge and opportunity for the Agency to improve the nutritional well-being of impoverished societies," write the authors of a Lancet Comment that examines the U.S. Global Hunger and Food Security Initiative. Though the initiative "sends a clear message to the world about U.S. intent to partner with poor nations to achieve their national food and nutrition goals … the Initiative's nutrition plan, unlike its detailed agricultural blueprint, currently lacks a comprehensive set of aims, activities, research needs, and programme benchmarks," the authors write.

29 Jan 2010

Agent-enhanced CT scan plays a supporting role in diagnosing severe cases of H1N1 flu virus

Published reports on the usefulness of CT scans for complicated H1N1 cases have spurred use of these procedures in U.S. hospitals. According to healthcare market research publisher Kalorama Information, this opens up a pathway of diagnostics for physicians and overall is a positive sign not only for the technology but also for companies making chemical agents for procedures.

29 Jan 2010

Quantrx Biomedical signs agreement to acquire NuRx Pharmaceuticals

QuantRx Biomedical Corporation today announced that it has entered into an agreement to acquire NuRx Pharmaceuticals, Inc. (OTCBB: NUXP). The transaction is structured as a tax-free, all stock acquisition resulting in a combined company with no debt and a simplified ownership and capital structure.

29 Jan 2010

ChromoCure retains Patent & Intellectual Property Attorneys to assess its Intellectual Property portfolio

ChromoCure, Inc. -- The Company announced today, based on the recent validation of its cancer detection approach and efficacy of its proprietary Chromosomal Scanning Technology, that it has retained Patent & Intellectual Property Attorneys to assess its growing Intellectual Property portfolio and secure necessary filings and Patent protections.

29 Jan 2010

Global market for oncology drugs is forecast to reach $80 billion by 2050

New Medicine's Oncology KnowledgeBASE (nm/OK) residing at http://nmok.net became available on the Internet 10 years ago and, since then, the oncology field has evolved into one of the most challenging, complex and promising drug development sectors, both in terms of its potential contribution to medicine and to its market opportunities.

29 Jan 2010

UCLA's non-invasive pre-surgical testing approach leads to seizure-free surgical outcome in TSC patients

When medication fails to control seizures in children with tuberous sclerosis complex (TSC), a rare genetic disorder that affects multiple organ systems and frequently causes epilepsy, surgery to remove part of the brain is often necessary. But pre-surgical testing, which involves the implanting of electrodes into a child's head, can lead to longer hospital stays and greater risks from surgery.

29 Jan 2010

Methodology and evidence behind national mammography guidelines is questionable, says JDMS review

The methodology and evidence behind a widely publicized change in national mammography guidelines is questionable, according to a review in the Journal of Diagnostic Medical Sonography (JDMS), published by SAGE.

29 Jan 2010

DNA Medicine Institute awarded Phase II NASA SBIR grant for developing nanoscale diagnostic technologies

DNA Medicine Institute, a commercial organization focused on advancing human health through innovation, today announced it has been awarded a Phase II Small Business Innovation Research (SBIR) contract from the National Aeronautics and Space Administration (NASA). The contract is designed to develop nanoscale diagnostic technologies that facilitate whole health analysis in a single drop of blood.

29 Jan 2010

QIAGEN hosts panel discussion to educate public about the emerging promise of personalized medicine

The treatment of illness has traditionally been based on the law of averages – what works best for the largest number of patients. As a result, billions of dollars are spent every year on treatments that could be ineffective or even harmful for some patients. What if doctors could tell with a simple test which course of treatment would be best for a particular patient?

From QIAGEN Manchester Limited 29 Jan 2010

Ultra–X BH selected as exclusive distributor for CTLM system in Brazil

Imaging Diagnostic Systems, Inc., a pioneer in laser optical breast imaging, announced today that Ultra–X BH has been selected as the exclusive distributor for the CT Laser Mammography (CTLM®) system throughout Brazil. The company will market the system to the private and public sector.

29 Jan 2010

Baylor Sammons Breast Center receives accreditation from NAPBC

Baylor Sammons Breast Center at Baylor University Medical Center at Dallas has been recognized by the National Accreditation Program for Breast Centers (NAPBC) for its "firm commitment to offer its patients every significant advantage in their battle against breast disease."

29 Jan 2010

AMP releases new position statement on the oversight of LDTs

Today, the Association for Molecular Pathology (AMP) released its new position statement on the oversight of laboratory developed tests (LDTs), a recent focus of debate among policy makers, the laboratory community and other stakeholders.

29 Jan 2010

CAMH signs licensing agreement to develop and market genetic test for degenerative muscle disorder

The Centre for Addiction and Mental Health (CAMH) has signed a licensing agreement with a Massachusetts firm to develop and market an innovative genetic test for a recently identified degenerative muscle disorder. The disorder tends to strike adults in their early 30s.

From Thermo Fisher Scientific Inc. 29 Jan 2010

NovaSom Diagnostic System approved for diagnostic evaluation of adults with OSA

Some 18-20 million Americans are at risk for Obstructive Sleep Apnea (OSA) and of those, only 5 to 10 percent have been diagnosed. Studies prove that fatality is a major risk of undiagnosed and untreated OSA; however, once detected, OSA can be readily and successfully treated.

29 Jan 2010

Diagnostic News and Research

Enzo Biochem generating more than $100M in revenues annually

USPTO allows claims to Rosetta Genomics' two microRNA related patent applications

PeaceHealth-San Juan Island community's new hospital initiative receives Certificate of Need approval

Redwood Consultants to assist DMI Life Sciences in shareholder relations and investor communications

Cardiologist provides heart-healthy tips for women

Rubicon Genomics reaches agreement with ZyGEM to market its PicoPlex single-cell amplification kits

Recent releases in Global Health

Agent-enhanced CT scan plays a supporting role in diagnosing severe cases of H1N1 flu virus

Quantrx Biomedical signs agreement to acquire NuRx Pharmaceuticals

ChromoCure retains Patent & Intellectual Property Attorneys to assess its Intellectual Property portfolio

Global market for oncology drugs is forecast to reach $80 billion by 2050

UCLA's non-invasive pre-surgical testing approach leads to seizure-free surgical outcome in TSC patients

Methodology and evidence behind national mammography guidelines is questionable, says JDMS review

DNA Medicine Institute awarded Phase II NASA SBIR grant for developing nanoscale diagnostic technologies

QIAGEN hosts panel discussion to educate public about the emerging promise of personalized medicine

Ultra–X BH selected as exclusive distributor for CTLM system in Brazil

Baylor Sammons Breast Center receives accreditation from NAPBC

AMP releases new position statement on the oversight of LDTs

CAMH signs licensing agreement to develop and market genetic test for degenerative muscle disorder

NovaSom Diagnostic System approved for diagnostic evaluation of adults with OSA

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News